XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Net revenues (Tables)
 6 Months Ended
Jun. 26, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments
The following table disaggregates revenue by global product category for the three and six months ended June 26, 2022 and June 27, 2021.
Three Months EndedSix Months Ended
June 26, 2022June 27, 2021June 26, 2022June 27, 2021
Vascular access$163,907 $167,739 $330,041 $331,712 
Anesthesia104,695 95,426 191,652 180,283 
Interventional114,342 112,082 211,201 208,255 
Surgical99,642 98,185 189,344 178,571 
Interventional urology79,818 92,243 154,713 165,607 
OEM70,003 60,956 127,659 114,445 
Other (1)
72,135 86,842 141,647 168,525 
Net revenues (2)
$704,542 $713,473 $1,346,257 $1,347,398 
(1)Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products). Certain product lines within the respiratory product category were sold during 2021. See Note 4 for additional information related to the Respiratory business divestiture.
(2)The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.